GLSI
Greenwich LifeSciences (GLSI)
$79
About Greenwich LifeSciences (GLSI)
Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.
Details
Daily high
$10.98
Daily low
$10.65
Price at open
$10.67
52 Week High
$20.55
52 Week Low
$10.20
Market cap
139.7M
Dividend yield
0.00%
Volume
26,592
Avg. volume
32,126
P/E ratio
-13.11
Greenwich LifeSciences News
Details
Daily high
$10.98
Daily low
$10.65
Price at open
$10.67
52 Week High
$20.55
52 Week Low
$10.20
Market cap
139.7M
Dividend yield
0.00%
Volume
26,592
Avg. volume
32,126
P/E ratio
-13.11